WallStreetZenWallStreetZen

NASDAQ: YMAB
Y Mabs Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Y Mabs Therapeutics revenue was $87.69M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $26.5M, up 43.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, YMAB annual revenue was $87.7M, with 3.4% growth year-over-year.

YMAB past revenue growth

How has YMAB's revenue growth performed historically?

Company
3.38%
Industry
497.69%
Market
20.68%
YMAB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
YMAB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
YMAB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

YMAB revenue history

Current Revenue
$87.7M
Current Earnings
-$29.7M
Current Profit Margin
-33.8%

Be the first to know when YMAB announces revenue.

YMAB Revenue History By Year

YMAB Yearly RevenueYMAB RevenueYMAB ChangeYMAB Revenue Growth
2024-12-31$87.69M$2.87M+3.38%
2023-12-31$84.82M$19.55M+29.96%
2022-12-31$65.27M$30.37M+87.03%
2021-12-31$34.90M$14.15M+68.18%
2020-12-31$20.75MN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Y Mabs Therapeutics Revenue FAQ

What was YMAB's revenue last quarter?

On Invalid Date, Y Mabs Therapeutics (NASDAQ: YMAB) reported Q4 2024 revenue of $26.50 million up 13.41% year over year. In the same quarter last year, Y Mabs Therapeutics's revenue was $23.36 million.

What was Y Mabs Therapeutics's revenue in 2024?

Y Mabs Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $87.69 million, a 3.38% increase year over year.

How much does Y Mabs Therapeutics make in a day?

Based on Y Mabs Therapeutics annual revenue for the past five years, YMAB makes an average of $160,776.99 per day.

What was Y Mabs Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Y Mabs Therapeutics's revenue has grown 3.38% year over year. This is 494.32 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Y Mabs Therapeutics's revenue in the past year totaled $87.69 million.

How much does Y Mabs Therapeutics make in a year?

Y Mabs Therapeutics's revenue by year for the past five years is:
  • Y Mabs Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $87.69 million, a 3.38% increase year over year.
  • Y Mabs Therapeutics's annual revenue for Dec 31, 2023 was $84.82 million, a 29.96% increase from 2022.
  • Y Mabs Therapeutics's annual revenue for 2022 was $65.27 million, a 87.03% increase from 2021.
  • Y Mabs Therapeutics's annual revenue for 2021 was $34.90 million, a 68.18% increase from 2020.
  • Y Mabs Therapeutics's annual revenue for 2020 was $20.75 million, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.